Systemic Diseases and the Eye examines ocular manifestations of diseases originating beyond the eye and highlights the role of ophthalmic findings in broader patient care. The session includes metabolic, autoimmune, neurological, cardiovascular, endocrine, infectious, and treatment-related conditions with important consequences for ocular health and vision.
Abstract Scope and Participation
Submissions may address ocular manifestations of systemic disease, interdisciplinary diagnosis, systemic treatment effects, biomarkers, screening, disease monitoring, and integrated management. Ophthalmologists, physicians, endocrinologists, rheumatologists, neurologists, researchers, and other specialists involved in multisystem disorders are invited to participate.







Title : Lenadogene nolparvovec gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom